Increased basal Rad51 levels in transformed cells compared to those in normal MEF cells, shown in this study, are consistent with the current notion that Rad51 is often overexpressed in tumor cells, resulting in increased resistance to genotoxic therapy [46,47]. The gene discussed is RAD51; the disease is neoplasm.